目的:低风险微小乳头状甲状腺癌(papillary thyroid carcinoma,PTC)的检出增加与过度诊断和治疗有关。N^(6)-甲基腺苷(N^(6)-methyladenosine,m^(6)A)修饰导致的微RNA(microRNAs,miRNA)失调在肿瘤转移和进展中发挥重要作用。然而,m^(6)...目的:低风险微小乳头状甲状腺癌(papillary thyroid carcinoma,PTC)的检出增加与过度诊断和治疗有关。N^(6)-甲基腺苷(N^(6)-methyladenosine,m^(6)A)修饰导致的微RNA(microRNAs,miRNA)失调在肿瘤转移和进展中发挥重要作用。然而,m^(6)A靶向miRNAs在PTC中的功能仍不清楚。本研究旨在探究m^(6)A-miR-139-5p在PTC中的表达调控机制,明确其与PTC转移的关联,并评估其作为PTC转移诊断生物标志物的潜力,为PTC的精准诊断和治疗提供实验依据。方法:通过癌症基因组图谱(The Cancer Genome Atlas,TCGA)和GSE130512队列筛选与PTC转移相关的候选靶向m^(6)A-miRNA分子。收集13例PTC转移患者和18例非转移患者的临床标本,检测m^(6)A-miR-139-5p的表达水平,分析其与转移的相关性。通过实验探究脂肪质量和肥胖相关蛋白(fat mass and obesity-associated protein,FTO)对pri-miR-139甲基化水平及加工过程的影响,明确其对miR-139-5p表达的调控作用。在TPC-1细胞中,通过四甲基偶氮唑盐(methyl thiazolyl tetrazolium,MTT)实验检测miR-139-5p过表达对FTO过表达介导的细胞增殖的影响。通过细胞侵袭实验验证miR-139-5p对PTC细胞侵袭能力的作用,并探究其是否通过靶向ZEB1/E-钙黏蛋白轴发挥功能。结果:通过比较TCGA和GSE130512队列,发现血清循环m^(6)A-miR-139-5p可作为检测PTC转移的生物指标。对13例转移和18例非转移临床标本的检测表明,FTO通过降低其甲基化水平抑制pri-miR-139的加工,导致miR-139-5p在PTC中表达失调(P<0.05)。在TPC-1细胞中,MTT实验显示miR-139-5p过表达可部分逆转FTO过表达介导的细胞增殖(P<0.05)。此外,miR-139-5p通过靶向ZEB1/E-钙黏蛋白轴抑制PTC细胞的侵袭能力,而FTO过表达可部分削弱这种抑制效应。结论:血清循环miR-139-5p可作为评估PTC转移的潜在标志物,FTO通过调控pri-miR-139的m^(6)A修饰影响miR-139-5的表达及功能,但其临床价值需进一步验证。展开更多
目的:基于SEER数据库的宫颈癌患者影响因素分析,分析影响宫颈癌预后的相关因素,为宫颈癌患者预后恢复及治疗提供科学参考依据。方法:利用SEER数据库初步筛查宫颈癌相关数据,从中下载所有符合研究的宫颈癌患者的不同病理分型的数据,选用...目的:基于SEER数据库的宫颈癌患者影响因素分析,分析影响宫颈癌预后的相关因素,为宫颈癌患者预后恢复及治疗提供科学参考依据。方法:利用SEER数据库初步筛查宫颈癌相关数据,从中下载所有符合研究的宫颈癌患者的不同病理分型的数据,选用第八期T,N,M分期对数据的T,N,M分期进行整理,标准化,筛选,筛选条件为患者第八期T,N,M分期明确,有符合要求的观察结局,如死亡或存活。通过筛查出的患者的不同病理分型的数据,运用SPSS26.0统计软件进行统计描述,采用Kaplan-Meier法。描绘生存曲线并估计患者的生存率,死亡率。生存时间分布的组间比较采用Log-Rank检验,对分析结果中P α = 0.05,以P Objective: Study on the prognostic risk model of cervical cancer patients based on SEER database, analyze the relevant factors affecting the prognosis of cervical cancer, and provide scientific reference for the prognosis recovery and treatment of cervical cancer patients. Methods: The SEER database was used to preliminarily screen the data related to cervical cancer, download the data of different pathological types of cervical cancer patients in line with the study, and select the eighth stage T, N, M to sort out, standardize and screen the T, N and M stages of the data. The screening conditions were that the eighth stage T, N and M stages of patients were clear, and there were satisfactory observed outcomes, such as death or survival. Through the data of different pathological types of patients screened, spss26 0 statistical software for statistical description, using Kaplan Meier method. Draw the survival curve and estimate the survival rate and mortality of patients. The inter group comparison of survival time distribution adopts log rank test to conduct multi factor Cox analysis on the variables with statistical significance of P α = 0.05, P < 0.05. Result: (1) Kaplan Meier univariate analysis: different pathological stages of T stage, N stage and M stage have an impact on the survival of patients, which is statistically significant (P < 0.05), and can affect the survival of patients to varying degrees. (2) Cox multivariate analysis: T stage, N stage and M stage were independent prognostic factors affecting the survival time of patients. Conclusion: Different T, N and M pathological stages of different cervical cancer patients can affect the prognosis of cervical cancer patients to varying degrees. They have a significant impact on the mortality and survival rate of cervical cancer patients, and can provide relevant basis for the development and improvement of the treatment scheme of cervical cancer.展开更多
文摘目的:低风险微小乳头状甲状腺癌(papillary thyroid carcinoma,PTC)的检出增加与过度诊断和治疗有关。N^(6)-甲基腺苷(N^(6)-methyladenosine,m^(6)A)修饰导致的微RNA(microRNAs,miRNA)失调在肿瘤转移和进展中发挥重要作用。然而,m^(6)A靶向miRNAs在PTC中的功能仍不清楚。本研究旨在探究m^(6)A-miR-139-5p在PTC中的表达调控机制,明确其与PTC转移的关联,并评估其作为PTC转移诊断生物标志物的潜力,为PTC的精准诊断和治疗提供实验依据。方法:通过癌症基因组图谱(The Cancer Genome Atlas,TCGA)和GSE130512队列筛选与PTC转移相关的候选靶向m^(6)A-miRNA分子。收集13例PTC转移患者和18例非转移患者的临床标本,检测m^(6)A-miR-139-5p的表达水平,分析其与转移的相关性。通过实验探究脂肪质量和肥胖相关蛋白(fat mass and obesity-associated protein,FTO)对pri-miR-139甲基化水平及加工过程的影响,明确其对miR-139-5p表达的调控作用。在TPC-1细胞中,通过四甲基偶氮唑盐(methyl thiazolyl tetrazolium,MTT)实验检测miR-139-5p过表达对FTO过表达介导的细胞增殖的影响。通过细胞侵袭实验验证miR-139-5p对PTC细胞侵袭能力的作用,并探究其是否通过靶向ZEB1/E-钙黏蛋白轴发挥功能。结果:通过比较TCGA和GSE130512队列,发现血清循环m^(6)A-miR-139-5p可作为检测PTC转移的生物指标。对13例转移和18例非转移临床标本的检测表明,FTO通过降低其甲基化水平抑制pri-miR-139的加工,导致miR-139-5p在PTC中表达失调(P<0.05)。在TPC-1细胞中,MTT实验显示miR-139-5p过表达可部分逆转FTO过表达介导的细胞增殖(P<0.05)。此外,miR-139-5p通过靶向ZEB1/E-钙黏蛋白轴抑制PTC细胞的侵袭能力,而FTO过表达可部分削弱这种抑制效应。结论:血清循环miR-139-5p可作为评估PTC转移的潜在标志物,FTO通过调控pri-miR-139的m^(6)A修饰影响miR-139-5的表达及功能,但其临床价值需进一步验证。
文摘目的:基于SEER数据库的宫颈癌患者影响因素分析,分析影响宫颈癌预后的相关因素,为宫颈癌患者预后恢复及治疗提供科学参考依据。方法:利用SEER数据库初步筛查宫颈癌相关数据,从中下载所有符合研究的宫颈癌患者的不同病理分型的数据,选用第八期T,N,M分期对数据的T,N,M分期进行整理,标准化,筛选,筛选条件为患者第八期T,N,M分期明确,有符合要求的观察结局,如死亡或存活。通过筛查出的患者的不同病理分型的数据,运用SPSS26.0统计软件进行统计描述,采用Kaplan-Meier法。描绘生存曲线并估计患者的生存率,死亡率。生存时间分布的组间比较采用Log-Rank检验,对分析结果中P α = 0.05,以P Objective: Study on the prognostic risk model of cervical cancer patients based on SEER database, analyze the relevant factors affecting the prognosis of cervical cancer, and provide scientific reference for the prognosis recovery and treatment of cervical cancer patients. Methods: The SEER database was used to preliminarily screen the data related to cervical cancer, download the data of different pathological types of cervical cancer patients in line with the study, and select the eighth stage T, N, M to sort out, standardize and screen the T, N and M stages of the data. The screening conditions were that the eighth stage T, N and M stages of patients were clear, and there were satisfactory observed outcomes, such as death or survival. Through the data of different pathological types of patients screened, spss26 0 statistical software for statistical description, using Kaplan Meier method. Draw the survival curve and estimate the survival rate and mortality of patients. The inter group comparison of survival time distribution adopts log rank test to conduct multi factor Cox analysis on the variables with statistical significance of P α = 0.05, P < 0.05. Result: (1) Kaplan Meier univariate analysis: different pathological stages of T stage, N stage and M stage have an impact on the survival of patients, which is statistically significant (P < 0.05), and can affect the survival of patients to varying degrees. (2) Cox multivariate analysis: T stage, N stage and M stage were independent prognostic factors affecting the survival time of patients. Conclusion: Different T, N and M pathological stages of different cervical cancer patients can affect the prognosis of cervical cancer patients to varying degrees. They have a significant impact on the mortality and survival rate of cervical cancer patients, and can provide relevant basis for the development and improvement of the treatment scheme of cervical cancer.
